Bunge Global vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
St. Louis global ag trader and processor (NYSE: BG) ~$45.8B FY2024 revenue; Viterra $8.2B acquisition pending 2025 closing, soybean crush/export, biofuel demand competing with ADM and Cargill.
About
Bunge Global SA is a St. Louis, Missouri-based agricultural commodities trader and food processing company — publicly traded on the New York Stock Exchange (NYSE: BG) as an S&P 500 Consumer Staples component, incorporated in Switzerland — processing oilseeds (soybeans, canola, sunflower) into vegetable oils and protein meals for food manufacturers, animal feed producers, and biodiesel refiners; trading grains and oilseeds globally through port elevators, inland grain terminals, and trading offices; and producing edible oils and specialty fats for consumer food brands through approximately 30,000 employees in 40+ countries. In fiscal year 2024, Bunge reported revenues of approximately $45.8 billion (declining from the 2022 commodity price peak as soybean crush margins normalized from supercycle levels), with adjusted EBITDA of approximately $1.5 billion from the Agribusiness, Refined Oils, and Milling segments. CEO Greg Heckman's defining strategic transaction: the pending acquisition of Viterra (Glencore's agricultural trading arm, formerly Viterra — handling grain, oilseed, and specialty crops origination and processing from Canada, Australia, and Europe) for $8.2 billion, announced in June 2023 and working through global competition authority approvals through 2024-2025 — creating a combined company with $60+ billion in combined revenues and market positions in North American, South American, European, and Australian grain origination that would rank alongside Archer-Daniels-Midland (ADM), Louis Dreyfus, and Cargill as a global agricultural trading leader. The Viterra combination (expected to close in mid-2025 after approval from EU, Canada, and Australia competition regulators) adds Viterra's Canadian canola origination (8+ million metric tons annually), Australian grain export infrastructure, and European oilseed and specialty crop handling to Bunge's Brazilian soy, US soybean, and Argentine origination platforms.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.